Allergy Skin Testing
JJ · Effective Oct 1, 2015
46 active Medicare policies list J44.9, and 20 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
J15 · Effective Apr 17, 2022
JE · Effective Apr 17, 2022
JF · Effective Apr 17, 2022
20 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Showing 10 of 14 · All Aetna policies
| Policy | Effective | Status of J44.9 |
|---|---|---|
| Analysis of Volatile Organic Compounds | Oct 3, 2023 | Covered |
| Chest Physiotherapy and Airway Clearance Devices | Mar 17, 2023 | Covered |
| Electrical Stimulation for Nausea, Vomiting, Motion Sickness and Other Selected Indications | Jan 5, 2024 | Covered |
| Enhanced External Counterpulsation (EECP) | Jun 7, 2023 | Covered |
| Exhaled Breath Tests | Sep 15, 2023 | Covered |
| Extracorporeal Shock-Wave Therapy for Musculoskeletal Indications and Soft Tissue Injuries |
JJ · Effective Apr 17, 2022
JM · Effective Apr 17, 2022
J5 · Effective Apr 17, 2022
J8 · Effective Apr 17, 2022
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Aug 6, 2026
National · Effective Aug 6, 2026
National · Effective May 14, 2026
J5 · Effective Aug 6, 2026
JL · Effective Jan 1, 2026
National · Effective Jan 1, 2026
National · Effective Oct 1, 2026
J6 · Effective Apr 1, 2026
National · Effective Jun 4, 2026
National · Effective Oct 1, 2026
JL · Effective Jan 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Jan 1, 2026
National · Effective Jan 1, 2026
J9 · Effective Feb 26, 2026
National · Effective Feb 1, 2026
| Sep 13, 2023 |
| Covered |
| Heart Transplantation | Aug 30, 2023 | Covered |
|---|
| Lung Denervation Therapy and Lung Volume Reduction Surgery | Mar 16, 2023 | Covered |
|---|
| Palivizumab (Synagis) | Feb 15, 2024 | Covered |
|---|
| Phonophoresis | Apr 11, 2023 | Covered |
|---|
| Policy | Effective | Status of J44.9 |
|---|---|---|
| Gamma Glutamyl Transferase Testing | Jul 1, 2026 | Covered |
| Mechanical Insufflation-Exsufflation Devices | Jul 1, 2026 | Covered |
| Noninvasive Home Ventilator Therapy for Respiratory Failure | Jul 1, 2026 | Covered |
| Outpatient Laboratory-based Blood Glucose Testing | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J44.9 |
|---|---|---|
| Polymerase Chain Reaction Respiratory Viral Panel Testing | Not recorded | Covered |
| Pulmonary Function Testing | Not recorded | Covered |